Business Context and Reporting Period
Company: AtlasClear Holdings, Inc. (NYSE American: ATCH)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended September 30, 2025
Business Overview: A fintech-driven business-to-business platform operating through its subsidiary, Wilson-Davis & Co., Inc., a self-clearing correspondent securities broker-dealer. The company focuses on trading, clearing, settlement, and banking services for financial firms, particularly in microcap securities.
Key Financial Metrics
| Metric | Q1 2025 (Three Months Ended Sept 30) | Q1 2024 (Three Months Ended Sept 30) |
|---|---|---|
| Total Revenues | $4,250,590 | $2,804,082 |
| Net Income (Loss) | $(440,294) | $10,748,033 |
| Loss from Operations | $(877,238) | $(941,102) |
| Net Cash Used in Operating Activities | $(2,500,236) | $175,607 |
| Cash and Cash Equivalents (End of Period) | $2,692,063 | $2,692,063 (Note: Q1 2024 cash not explicitly stated in summary table, but Q3 2025 total cash including restricted is $32.2M) |
| Total Assets | $73,634,759 | $55,994,817 |
| Total Liabilities | $66,778,576 | $67,690,281 |
| Stockholders' Deficit | $6,856,183 | $(23,162,035) |
Note: The prior period (Q1 2024) net income was significantly inflated by non-cash gains on derivative liabilities. The current period reflects a return to operational losses.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased by 52% ($1.45M) year-over-year, driven primarily by a $825K increase in "Other revenue" and a $951K increase in commissions. Clearing fees decreased by $333K.
- Expense Increase: Total expenses rose by $1.38M to $5.13M. The primary driver was a $1.84M increase in compensation, payroll taxes, and benefits, attributed to variable compensation tied to revenue growth. Stock-based compensation of $155K was recorded for new executive agreements, compared to zero in the prior period.
- Net Income Volatility: The company swung from a net income of $10.75M in Q1 2024 to a net loss of $440K in Q1 2025. The prior year's income was largely artificial, driven by an $11.15M gain from the change in fair value of long-term and short-term note derivatives. These instruments were settled or converted in the current period, eliminating the non-cash gain.
- Balance Sheet Shift: Stockholders' deficit improved from $(23.2M) to a positive equity position of $6.86M, primarily due to the conversion of significant debt obligations into equity (over $13M in principal converted to shares during the quarter).
Guidance, Outlook, Risks, and Unusual Items
- Going Concern Alleviated: While the company previously raised substantial doubt about its ability to continue as a going concern due to recurring losses, this was alleviated by subsequent financing events in October 2025. The company secured approximately $15.75M in aggregate gross proceeds through a Restated Secured Convertible Note ($10M) and an Equity SPA ($10M, including $4.25M converted from prior notes).
- Subsequent Events:
- October 2025 Financing: Issued a Restated Note with Funicular Funds (11% interest, 5-year maturity) and sold Units (Common Stock + Warrants) to institutional investors.
- Debt Settlements: Settled remaining balances of the Chardan Note, Merger Financing Note, and Seller Notes via share conversions.
- Risk Factors:
- Derivative Volatility: Significant exposure to fair value changes of embedded derivatives in debt instruments, which can cause extreme earnings volatility.
- Liquidity: Reliance on continued access to capital markets to fund operations and service debt.
- Regulatory: Ongoing FINRA proceedings regarding Wilson-Davis fines (reduced to $490K, under appeal); contingent liability of $100K accrued.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2025.
- Unusual Items: The "Other revenue" line item increased significantly to $830K, though the filing does not provide a granular breakdown of this specific increase in the MD&A section.
Investor Verification Checklist
- Verify Subsequent Financing Terms: Confirm the final closing details and dilution impact of the October 2025 Restated Note and Equity SPA, which are critical to the company's liquidity.
- Assess Derivative Liability Exposure: Review the remaining fair value of derivative liabilities (e.g., Earnout liability of $11.5M, Debenture derivative of $1.2M) and their potential impact on future earnings.
- Monitor Internal Control Remediation: Track the company's progress in remediating the ineffective disclosure controls and procedures identified in this filing.
- Review FINRA Appeal Status: Monitor the outcome of the appeal regarding the $490K fine to determine if additional liabilities will be recognized.
- Validate Revenue Quality: Investigate the composition of the $830K "Other revenue" to ensure it represents sustainable operating income rather than one-time items.